With three Covid-19 vaccines proving effective, we ask fund manager John Bowler and Data Insights Unit head Mark Ainsworth what comes next as regards the pandemic, and what the future holds for healthcare investing.
Register or log in to continue reading. Investment Officer is an independent journalism platform for professionals working in the Luxembourg investment industry.
A subscription is free for professionals working at banks and independent asset managers.
